Nerve agent intoxication: Recent neuropathophysiological findings and subsequent impact on medical management prospects

Toxicology and Applied Pharmacology

Volumn 255, Issue 3, 2011, Pages 229-241

  Collombet, Jean Marc ^a  

^a CENTRE DE RECHERCHES   (France)

Author keywords

Angiogenesis; Cognitive behavior; Delayed treatment; Glia; Nerve agent; Neurogenesis; Neuropathology; Organophosphate

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; ATROPINE; ATROPINE PLUS AVIZAFONE PLUS PRALIDOXIME; BENZODIAZEPINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINESTERASE; CILIARY NEUROTROPHIC FACTOR; DIAZEPAM DERIVATIVE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; INEUROPE; KETAMINE; ORGANOPHOSPHATE; OXIME; PRALIDOXIME MESILATE; PRODRUG; PYRIDOSTIGMINE; SARIN; SOMAN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMYGDALOID NUCLEUS; ANGIOGENESIS; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; CONVALESCENCE; DRUG EFFECT; DRUG EFFICACY; EMERGENCY TREATMENT; HIPPOCAMPUS; HUMAN; INTOXICATION; NERVE AGENT INTOXICATION; NERVE FIBER REGENERATION; NERVE GAS INTOXICATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL TRANSPLANTATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; REVIEW;

MUS; RODENTIA;

EID: 80052365609     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.07.003     Document Type: Review

References (110)

1. Apland J.P., Figueiredo T.H., Qashu F., Aroniadou-Anderjaska V., Souza A.P., Braga M.F. Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology. Neurotoxicology 2010, 31:485-492.
2. Baille V., Clarke P.G., Brochier G., Dorandeu F., Verna J.M., Four E., Lallement G., Carpentier P. Soman-induced convulsions: the neuropathology revisited. Toxicology 2005, 215:1-24.
3. Baille-Le Crom V., Collombet J.M., Carpentier P., Brochier G., Burckhart M.F., Foquin A., Pernot-Marino I., Rondouin G., Lallement G. Early regional changes of GFAP mRNA in rat hippocampus and dentate gyrus during soman-induced seizures. Neuroreport 1995, 7:365-369.
4. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004, 38:151-216.
5. Bauer S., Kerr B.J., Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Rev. Neurosci. 2007, 8:221-232.
6. Borsello T., Di Luzio A., Ciotti M.T., Calissano P., Galli C. Granule neuron DNA damage following deafferentation in adult rats cerebellar cortex: a lesion model. Neuroscience 2000, 95:163-171.
7. Bridges R.S., Grattan D.R. Prolactin-induced neurogenesis in the maternal brain. Trends Endocrinol. Metab. 2003, 14:199-201.
8. Brockington A., Lewis C., Wharton S., Shaw P.J. Vascular endothelial growth factor and the nervous system. Neuropathol. Appl. Neurobiol. 2004, 30:427-446.
9. Burns T.C., Verfaillie C.M., Low W.C. Stem cells for ischemic brain injury: a critical review. J. Comp. Neurol. 2009, 515:125-144.
10. Capurso S.A., Calhoun M.E., Sukhov R.R., Mouton P.R., Price D.L., Koliatsos V.E. Deafferentation causes apoptosis in cortical sensory neurons in the adult rat. J. Neurosci. 1997, 17:7372-7384.
11. Carpentier P., Foquin A., Kamenka J.M., Rondouin G., Lerner-Natoli M., de Groot D.M., Lallement G. Effects of thienylphencyclidine (TCP) on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neurotoxicity. Neurotoxicology 2001, 22:13-28.
12. Chapman S., Kadar T., Gilat E. Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. Neurotoxicology 2006, 27:277-283.
13. Chen Y., Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 2003, 23:137-149.
14. Chu C.T. Autophagic stress in neuronal injury and disease. J. Neuropathol. Exp. Neurol. 2006, 65:423-432.
15. Collombet J.M., Mourcin F., Grenier N., Four E., Masqueliez C., Baubichon D., Lallement G., Herodin F. Effect of soman poisoning on populations of bone marrow and peripheral blood cells in mice. Neurotoxicology 2005, 26:89-98.
16. Collombet J.M., Four E., Bernabe D., Masqueliez C., Burckhart M.F., Baille V., Baubichon D., Lallement G. Soman poisoning increases neural progenitor proliferation and induces long-term glial activation in mouse brain. Toxicology 2005, 208:319-334.
17. Collombet J.M., Four E., Burckhart M.F., Masqueliez C., Bernabe D., Baubichon D., Herodin F., Lallement G. Effect of cytokine treatment on the neurogenesis process in the brain of soman-poisoned mice. Toxicology 2005, 210:9-23.
18. Collombet J.M., Carpentier P., Baille V., Four E., Bernabe D., Burckhart M.F., Masqueliez C., Baubichon D., Lallement G. Neuronal regeneration partially compensates the delayed neuronal cell death observed in the hippocampal CA1 field of soman-poisoned mice. Neurotoxicology 2006, 27:201-209.
19. Collombet J.M., Masqueliez C., Four E., Burckhart M.F., Bernabe D., Baubichon D., Lallement G. Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus. Neurosci. Lett. 2006, 398:337-342.
20. Collombet J.M., Four E., Fauquette W., Burckhart M.F., Masqueliez C., Bernabe D., Baubichon D., Lallement G. Soman poisoning induces delayed astrogliotic scar and angiogenesis in damaged mouse brain areas. Neurotoxicology 2007, 28:38-48.
21. Collombet J.M., Pierard C., Beracochea D., Coubard S., Burckhart M.F., Four E., Masqueliez C., Baubichon D., Lallement G. Long-term consequences of soman poisoning in mice. Part 1. Neuropathology and neuronal regeneration in the amygdala. Behav. Brain Res. 2008, 191:88-94.
22. Collombet J.M., Beracochea D., Liscia P., Pierard C., Lallement G., Filliat P. Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice. Behav. Brain Res. 2011, 221:261-270.
23. Coubard S., Beracochea D., Collombet J.M., Philippin J.N., Krazem A., Liscia P., Lallement G., Pierard C. Long-term consequences of soman poisoning in mice: part 2. Emotional behavior. Behav. Brain Res. 2008, 191:95-103.
24. Croll S.D., Ransohoff R.M., Cai N., Zhang Q., Martin F.J., Wei T., Kasselman L.J., Kintner J., Murphy A.J., Yancopoulos G.D., Wiegand S.J. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp. Neurol. 2004, 187:388-402.
25. Dhote F., Peinnequin A., Carpentier P., Baille V., Delacour C., Foquin A., Lallement G., Dorandeu F. Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007, 238:166-176.
26. Dong H., Csernansky C.A., Goico B., Csernansky J.G. Hippocampal neurogenesis follows kainic acid-induced apoptosis in neonatal rats. J. Neurosci. 2003, 23:1742-1749.
27. Dorandeu F., Mikler J.R., Thiermann H., Tenn C., Davidson C., Sawyer T.W., Lallement G., Worek F. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning. Toxicology 2007, 233:128-144.
28. Dorandeu F., Baille V., Mikler J., Testylier G., Lallement G., Sawyer T., Carpentier P. Protective effects of S+ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs. Toxicology 2007, 234:185-193.
29. Dusart I., Marty S., Peschanski M. Glial changes following an excitotoxic lesion in the CNS-II. Astrocytes. Neuroscience 1991, 45:541-549.
30. Einstein O., Ben-Hur T. The changing face of neural stem cell therapy in neurologic diseases. Arch. Neurol. 2008, 65:452-456.
31. Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029.
32. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 1999, 49:377-391.
33. Filliat P., Coubard S., Pierard C., Liscia P., Beracochea D., Four E., Baubichon D., Masqueliez C., Lallement G., Collombet J.M. Long-term behavioral consequences of soman poisoning in mice. Neurotoxicology 2007, 28:508-519.
34. Fujikawa D.G., Shinmei S.S., Cai B. Seizure-induced neuronal necrosis: implications for programmed cell death mechanisms. Epilepsia 2000, 41(Suppl 6):S9-S13.
35. Fukuda T., Nakano S., Yoshiya I., Hashimoto P.H. Persistent degenerative state of non-pyramidal neurons in the CA1 region of the gerbil hippocampus following transient forebrain ischemia. Neuroscience 1993, 53:23-38.
36. Ginsberg S.D., Portera-Cailliau C., Martin L.J. Fimbria-fornix transection and excitotoxicity produce similar neurodegeneration in the septum. Neuroscience 1999, 88:1059-1071.
37. Gora-Kupilas K., Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 2005, 43:31-39.
38. Graham B.M., Richardson R. Acute systemic fibroblast growth factor-2 enhances long-term extinction of fear and reduces reinstatement in rats. Neuropsychopharmacology 2009, 34:1875-1882.
39. Greenberg D.A., Jin K. From angiogenesis to neuropathology. Nature 2005, 438:954-959.
40. Hagg T. Molecular regulation of adult CNS neurogenesis: an integrated view. Trends Neurosci. 2005, 28:589-595.
41. Harrigan M.R. Angiogenic factors in the central nervous system. Neurosurgery 2003, 53:639-660.
42. Herx L.M., Yong V.W. Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J. Neuropathol. Exp. Neurol. 2001, 60:961-971.
43. Herx L.M., Rivest S., Yong V.W. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 2000, 165:2232-2239.
44. Hopkins K.J., Wang G., Schmued L.C. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 2000, 864:69-80.
45. Huang Y.J., Huang Y., Baldassarre H., Wang B., Lazaris A., Leduc M., Bilodeau A.S., Bellemare A., Cote M., Herskovits P., Touati M., Turcotte C., Valeanu L., Lemee N., Wilgus H., Begin I., Bhatia B., Rao K., Neveu N., Brochu E., Pierson J., Hockley D.K., Cerasoli D.M., Lenz D.E., Karatzas C.N., Langermann S. Recombinant human butyrylcholinesterase from milk of transgenic animals to protect against organophosphate poisoning. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13603-13608.
46. Johnson E.A., Kan R.K. The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J. Neuroinflammation. 2010, 7:40-48.
47. Kadar T., Cohen G., Sahar R., Alkalai D., Shapira S. Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum. Exp. Toxicol. 1992, 11:517-523.
48. Kadivar H., Adams S.C. Treatment of chemical and biological warfare injuries: insights derived from the 1984 Iraqi attack on Majnoon Island. Mil. Med. 1991, 156:171-177.
49. Kempermann G., Neumann H. Neuroscience. Microglia: the enemy within?. Science 2003, 302:1689-1690.
50. Komitova M., Mattsson B., Johansson B.B., Eriksson P.S. Enriched environment increases neural stem/progenitor cell proliferation and neurogenesis in the subventricular zone of stroke-lesioned adult rats. Stroke 2005, 36:1278-1282.
51. Krum J.M., Khaibullina A. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Exp. Neurol. 2003, 181:241-257.
52. Krum J.M., Mani N., Rosenstein J.M. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002, 110:589-604.
53. Lallement G., Delamanche I.S., Pernot-Marino I., Baubichon D., Denoyer M., Carpentier P., Blanchet G. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an omega 3 site ligand. Brain Res. 1993, 618:227-237.
54. Lallement G., Dorandeu F., Filliat P., Carpentier P., Baille V., Blanchet G. Medical management of organophosphate-induced seizures. J. Physiol. Paris 1998, 92:369-373.
55. Lallement G., Clair P., Zabé D. A new autoinjector for emergency self-treatment of nerve gas poisoning with an improved pharmaceutical concept and design. ASA Newsl. 2007, 1:24-25.
56. Lemercier G., Carpentier P., Sentenac-Roumanou H., Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. (Berl.) 1983, 61:123-129.
57. Li Y., Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 2009, 456:120-123.
58. Liberto C.M., Albrecht P.J., Herx L.M., Yong V.W., Levison S.W. Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 2004, 89:1092-1100.
59. Lindvall O., Kokaia Z. Stem cells for the treatment of neurological disorders. Nature 2006, 441:1094-1096.
60. Liu X.B., Wang J.A., Yu S.P., Keogh C.L., Wei L. Therapeutic strategy of erythropoietin in neurological disorders. CNS Neurol. Disord. Drug Targets 2008, 7:227-234.
61. Mamczarz J., Pereira E.F., Aracava Y., Adler M., Albuquerque E.X. An acute exposure to a sub-lethal dose of soman triggers anxiety-related behavior in guinea pigs: interactions with acute restraint. Neurotoxicology 2010, 31:77-84.
62. Marty S., Dusart I., Peschanski M. Glial changes following an excitotoxic lesion in the CNS-I. Microglia/macrophages. Neuroscience 1991, 45:529-539.
63. Masson P., Nachon F., Broomfield C.A., Lenz D.E., Verdier L., Schopfer L.M., Lockridge O. A collaborative endeavor to design cholinesterase-based catalytic scavengers against toxic organophosphorus esters. Chem. Biol. Interact. 2008, 175:273-280.
64. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21:559-579.
65. McDonough J.H., Clark T.R., Slone T.W., Zoeffel D., Brown K., Kim S., Smith C.D. Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman. Neurotoxicology 1998, 19:381-391.
66. Merrill M.J., Oldfield E.H. A reassessment of vascular endothelial growth factor in central nervous system pathology. J. Neurosurg. 2005, 103:853-868.
67. Meyer C. L'arme Chimique 2001, Ellipses, Paris.
68. Miller A.L., Medina M.A. Cerebral metabolic effects of organophosphorus anticholinesterase compounds. Metab. Brain Dis. 1986, 1:147-156.
69. Millerioux J., Cruz C., Bazire A., Polly V., Lallement G., Lefeuvre L., Josse D. Evaluation of in vitro tests to assess the efficacy of formulations as topical skin protectants against organophosphorus compounds. Toxicol. In Vitro 2009, 23:127-133.
70. Morita H., Yanagisawa N., Nakajima T., Shimizu M., Hirabayashi H., Okudera H., Nohara M., Midorikawa Y., Mimura S. Sarin poisoning in Matsumoto, Japan. Lancet 1995, 346:290-293.
71. Nakamura Y. Regulating factors for microglial activation. Biol. Pharm. Bull. 2002, 25:945-953.
72. Nakatomi H., Kuriu T., Okabe S., Yamamoto S., Hatano O., Kawahara N., Tamura A., Kirino T., Nakafuku M. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002, 110:429-441.
73. Nithianantharajah J., Hannan A.J. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 2006, 7:697-709.
74. Okano H., Sawamoto K. Neural stem cells: involvement in adult neurogenesis and CNS repair. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:2111-2122.
75. O'Keefe J., Nadel L. The Hippocampus as a Cognitive Map 1978, Oxford University Press, Oxford.
76. Onodera H., Aoki H., Kogure K. Long-term structural and biochemical events in the hippocampus following transient global ischemia. Prog. Brain Res. 1993, 96:271-280.
77. Paizanis E., Hamon M., Lanfumey L. Hippocampal neurogenesis, depressive disorders, and antidepressant therapy. Neural Plast. 2007, 73754-73761.
78. Parent J.M. Adult neurogenesis in the intact and epileptic dentate gyrus. Prog. Brain Res. 2007, 163:529-540.
79. Park J.H., Cho H., Kim H., Kim K. Repeated brief epileptic seizures by pentylenetetrazole cause neurodegeneration and promote neurogenesis in discrete brain regions of freely moving adult rats. Neuroscience 2006, 140:673-684.
80. Perez J.A., Clinton S.M., Turner C.A., Watson S.J., Akil H. A new role for FGF2 as an endogenous inhibitor of anxiety. J. Neurosci. 2009, 29:6379-6387.
81. Pernot F., Carpentier P., Baille V., Testylier G., Beaup C., Foquin A., Filliat P., Liscia P., Coutan M., Pierard C., Beracochea D., Dorandeu F. Intrahippocampal cholinesterase inhibition induces epileptogenesis in mice without evidence of neurodegenerative events. Neuroscience 2009, 162:1351-1365.
82. Petras J.M. Neurology and neuropathology of Soman-induced brain injury: an overview. J. Exp. Anal. Behav. 1994, 61:319-329.
83. Phelps E.A., LeDoux J.E. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005, 48:175-187.
84. Phinney D.G., Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr. Pharm. Des. 2005, 11:1255-1265.
85. Puig B., Ferrer I. Caspase-3-associated apoptotic cell death in excitotoxic necrosis of the entorhinal cortex following intraperitoneal injection of kainic acid in the rat. Neurosci. Lett. 2002, 321:182-186.
86. Rampon C., Tang Y.P., Goodhouse J., Shimizu E., Kyin M., Tsien J.Z. Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat. Neurosci. 2000, 3:238-244.
87. Renaudeau C. Les agressifs chimiques de guerre. Menace Terroriste: Approche Médicale 2005, 317-326. John Libbey Eurotext, Montrouge. T. De Revel, P. Gourmelon, D. Vidal, C. Renaudeau (Eds.).
88. Rochu D., Chabriere E., Masson P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 2007, 233:47-59.
89. Salhia B., Angelov L., Roncari L., Wu X., Shannon P., Guha A. Expression of vascular endothelial growth factor by reactive astrocytes and associated neoangiogenesis. Brain Res. 2000, 883:87-97.
90. Scharfman H.E., Goodman J.H., Sollas A.L. Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J. Neurosci. 2000, 20:6144-6158.
91. Shacka J.J., Lu J., Xie Z.L., Uchiyama Y., Roth K.A., Zhang J. Kainic acid induces early and transient autophagic stress in mouse hippocampus. Neurosci. Lett. 2007, 414:57-60.
92. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
93. Sotiropoulou P.A., Papamichail M. Immune properties of mesenchymal stem cells. Methods Mol. Biol. 2007, 407:225-243.
94. Stoll G., Jander S., Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv. Exp. Med. Biol. 2002, 513:87-113.
95. Suzuki T., Morita H., Ono K., Maekawa K., Nagai R., Yazaki Y. Sarin poisoning in Tokyo subway. Lancet 1995, 345:980.
96. Svensson I., Waara L., Johansson L., Bucht A., Cassel G. Soman-induced interleukin-1 beta mRNA and protein in rat brain. Neurotoxicology 2001, 22:355-362.
97. Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res. Rev. 2007, 53:198-214.
98. Tran K.C., Ryu J.K., McLarnon J.G. Induction of angiogenesis by platelet-activating factor in the rat striatum. Neuroreport 2005, 16:1579-1583.
99. Tryphonas L., Clement J.G. Histomorphogenesis of soman-induced encephalocardiomyopathy in Sprague-Dawley rats. Toxicol. Pathol. 1995, 23:393-409.
100. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 2006, 36:2566-2573.
101. Wang W., Redecker C., Bidmon H.J., Witte O.W. Delayed neuronal death and damage of GDNF family receptors in CA1 following focal cerebral ischemia. Brain Res. 2004, 1023:92-101.
102. Whitney N.P., Eidem T.M., Peng H., Huang Y., Zheng J.C. Inflammation mediates varying effects in neurogenesis: relevance to the pathogenesis of brain injury and neurodegenerative disorders. J. Neurochem. 2009, 108:1343-1359.
103. Will B., Galani R., Kelche C., Rosenzweig M.R. Recovery from brain injury in animals: relative efficacy of environmental enrichment, physical exercise or formal training (1990-2002). Prog. Neurobiol. 2004, 72:167-182.
104. Williams A.J., Berti R., Yao C., Price R.A., Velarde L.C., Koplovitz I., Schultz S.M., Tortella F.C., Dave J.R. Central neuro-inflammatory gene response following soman exposure in the rat. Neurosci. Lett. 2003, 349:147-150.
105. Yakovlev A.G., Faden A.I. Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx 2004, 1:5-16.
106. Yanagisawa N., Morita H., Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J. Neurol. Sci. 2006, 249:76-85.
107. Yuan J., Lipinski M., Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003, 40:401-413.
108. Zand L., Ryu J.K., McLarnon J.G. Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampus. Neuroreport 2005, 16:129-132.
109. Zhao C., Deng W., Gage F.H. Mechanisms and functional implications of adult neurogenesis. Cell 2008, 132:645-660.
110. Zimmer L.A., Ennis M., Shipley M.T. Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions. J. Comp. Neurol. 1997, 378:482-492.